Michael Fox
Has grant
Director, Center for Brain Circuit Therapeutics
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease
Open Date: 2021-04-15
Close Date: 2023-03-31
Grant: Close
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation
Open Date: 2021-04-01
Close Date: 2023-03-31
Grant: Close
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
Open Date: 2017-09-19
Close Date: 2022-08-31
Grant: Close
Use of Resting-State Networks to Predict the Ideal Site for Brain Stimulation
Open Date: 2013-08-15
Close Date: 2018-05-31
Grant: Close
Functional Relevance of Spontaneous BOLD Fluctuations
Open Date: 2006-01-01
Close Date: 2008-05-16
Articles (20)
Year:
2025
Oculogyric crises are acute episodes of sustained, typically upward, conjugate deviation of the eyes. Oculogyric crises usually occur as the result of acute D2-dopamine receptor blockade, but the brain areas causally involved in generating this symptom remain elusive. Here, we used data from 14 previously reported cases of lesion-induced oculogyric crises and employed lesion network mapping to identify their shared connections throughout the brain. This analysis yielded a common network that included basal ganglia, thalamic, and brainstem nuclei, as well as the cerebellum. Comparison of this network with gene expression profiles associated with the dopamine system revealed spatial overlap specifically with the gene coding for dopamine receptor type 2 (DRD2) as defined by a large-scale transcriptomic database of the human brain. Furthermore, spatial overlap with DRD2 and DRD3 gene expression was specific to brain lesions associated with oculogyric crises when contrasted to lesions that led to other movement disorders. Our findings identify a common neural network causally involved in the occurrence of oculogyric crises and provide a pathophysiological link between lesion locations causing this syndrome and its most common pharmacological cause, namely DRD2 blockade.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (16)
Luis Concha
Professor
National Autonomous University of Mexico
Patricia Krause
Charité - Universitätsmedizin Berlin
Patricia Zvarova
Charité - Universitätsmedizin Berlin
Aristotelis Kalyvas
Assistant Professor
University of Toronto
Gillian Coughlan
Assistant Professor
Massachusetts General Hospital and Harvard Medical School
Maximilian Friedrich
Attending Neurologist | Research Group Leader
University Hospital Ulm
Erica Baller
Assistant Professor of Psychiatry
University of Pennsylvania
Frank Guenther
Professor
Boston University
Markus D. Schirmer
Amsterdam University Medical Centers
Natalia Rost
Professor
Massachusetts General Hospital
Christos Ganos
Director
-
Wolf-Julian Neumann
Head of AI Innovation and Therapeutic Neurotechnology
Charité - Universitätsmedizin Berlin
Richard Darby
Vanderbilt University Medical Center
Esther Florin
Heinrich Heine University Düsseldorf
Isaiah Kletenik
Assistant Professor of Neurology
Harvard Medical School
Susanne van Veluw
University of Edinburgh
Make your next move.
Prepare your application
Review drafts before you send them.